Immunoglobulin VH gene analysis in gastric MALT lymphomas

Modern Pathology

Volumn 20, Issue 4, 2007, Pages 460-466

  Sakuma, Hidenori ^a   Nakamura, Tsuneya ^b   Uemura, Naomi ^c   Chiba, Tsutomu ^d   Sugiyama, Toshiro ^e   Asaka, Masahiro ^f   Akamatsu, Taiji ^g   Ueda, Ryuzo ^a   Eimoto, Tadaaki ^a   Goto, Hidemi ^h   Nakamura, Shigeo ^h   Inagaki, Hiroshi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g SHINSHU UNIVERSITY HOSPITAL   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

API2 MALT1 fusion gene; Eradication; Gastric MALT lymphoma; Helicobacter pylori; Immunoglobulin heavy chain variable genes

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE; GENETIC ANALYSIS; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN VH GENE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; SOMATIC MUTATION; STOMACH MUCOSA; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE EXPRESSION; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS;

EID: 33947581028     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800758     Document Type: Article

References (34)

1. Isaacson PG, Berger F, Muller-Hermelink HK, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. IARC Press: Lyon, 2001, pp 157-160.
2. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.
3. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601-3609.
4. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000;156:1183-1188.
5. Roy N, Deveraux QL, Takahashi R, et al. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997;16:6914-6925.
6. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001;276:19012-19019.
7. Hosokawa Y, Suzuki H, Suzuki Y, et al. Antiapoptotic function of apoptosis inhibitor2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma. Cancer Res 2004;64:3452-3457.
8. Inagaki H, Nakamura T, Li C, et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 2004;28:1560-1567.
9. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosaassociated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001;357:39-40.
10. Liu H, Ye H, Dogan A, et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001;98:1182-1187.
11. Ye H, Liu H, Raderer M, et al. High incidence of t(11;18)(q21;q21) in Helicobacter pylori negative gastric MALT lymphoma. Blood 2003;101:2547-2550.
12. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751-758.
13. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995;16:237-242.
14. H 3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003;101:4952-4957.
15. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002;99:2262-2264.
16. Algara P, Mateo MS, Sanchez-Beato M, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002;99:1299-1304.
17. Miklos JA, Swerdlow SH, Bahler DW. Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features. Blood 2000;95:3878-3884.
18. Yoshida M, Okabe M, Eimoto T, et al. Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutated. J Pathol 2006;208:415-422.
19. Du MQ, Diss TC, Xu C, et al. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 1996;10:1190-1197.
20. Fujimori K, Shimodaira S, Akamatsu T, et al. Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma. Br J Cancer 2005;92:312-319.
21. Nardini E, Rizzi S, Menard S, et al. Molecular phenotype distinguishes two subsets of gastric lowgrade mucosa-associated lymphoid tissue lymphomas. Lab Invest 2002;82:535-541.
22. Qin Y, Greiner A, Hallas C, et al. Intraclonal offspring expansion of gastric low-grade MALT-type lymphoma: evidence for role of antigen-driven high-affinity mutation in lymphomagenesis. Lab Invest 1997;76:477-485.
23. Inagaki H, Okabe M, Seto M, et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001;158:699-706.
24. Okabe M, Inagaki H, Ohshima K, et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 2003;162:1113-1122.
25. Conconi A, Bertoni F, Pedrinis E, et al. Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. Blood 2001;98:781-786.
26. Inagaki H, Chan JK, Ng JW, et al. Primary thymic extranodal marginal-zone B-cell lymphoma of mucosaassociated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol 2002;160:1435-1443.
27. Lossos IS, Okada CY, Tibshirani R, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood 2000;95:1797-1803.
28. Hoffmann M, Uttenreuther-Fischer MM, Lerch H, et al. IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germline gene origin as in autoimmune thrombocytopenia. Clin Exp Immunol 2000;121:37-46.
29. H3 gene usage in phage-displayed Fab that are selected by intravenous immunoglobulin. Arthritis Rheum 2000;43:2722-2732.
30. Shin EK, Akamizu T, Matsuda F, et al. Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease. J Immunol 1994;152:1485-1492.
31. Sibilia J, Benlagha K, Vanhille P, et al. Structural analysis of human antibodies to proteinase 3 from patients with Wegener granulomatosis. J Immunol 1997;159:712-719.
32. Leucht S, Uttenreuther-Fischer MM, Gaedicke G, et al. The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy. Clin Immunol 2001;99:18-29.
33. Kuppers R, Klein U, Hansmann ML, et al. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-1529.
34. Spencer JO, Dunn-Walters DK. Somatic hypermutation and B-cell malignancies. J Pathol 1999;187:158-163.